Since the levels of tumor markers (AFP and DCP), tumor sizes, numbers and vascular invasion were comparable in patients with HCC treated with PBT and TACE + RFA therapies as seen in Table 1, we evaluated the changes of ALBI score after the treatments in the patients to monitor their hepatic reserve in Figure 3. Here, AFP is linked to hepatocellular carcinoma.